ArticleEuropean heart journal2025

The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibition.

Kai-Uwe Jarr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.